2014
Braun KL, Tsark JU, Powers A, Croom K, Kim R, Gachupin FC, Morris P. 2014. Cancer patient perceptions about biobanking and preferred timing of consent. Biopreserv Biobank. 12:106–12. doi:10.1089/bio.2013.0083.
Miller CR, Oliver KE, Farley JH. 2014. MEK1/2 inhibitors in the treatment of gynecologic malignancies. Gynecol Oncol. 133:128–37. doi:10.1016/j.ygyno.2014.01.008.
Riahi R, Yang YL, Kim H, Jiang L, Wong PK, Zohar Y. 2014. A microfluidic model for organ-specific extravasation of circulating tumor cells. Biomicrofluidics. 8:024103. doi:10.1063/1.4868301.
Hatcher-Keller J, Rayens MK, Dignan M, Schoenberg N, Allison P. 2014. Beliefs regarding mammography screening among women visiting the emergency department for nonurgent care. J Emerg Nurs. 40:e27–35. doi:10.1016/j.jen.2013.01.015.
Weinstein RS, López AM, Joseph BA, Erps KA, Holcomb M, Barker GP, Krupinski EA. 2014. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med. 127:183–7. doi:10.1016/j.amjmed.2013.09.032.
Cusanovich DA, Pavlovic B, Pritchard JK, Gilad Y. 2014. The functional consequences of variation in transcription factor binding. PLoS Genet. 10:e1004226. doi:10.1371/journal.pgen.1004226.
Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA. 2014. Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev. 23:255–73. doi:10.1158/1055-9965.EPI-13-0515.
Tredwell GD, Miller JA, Chow H-HS, Thompson PA, Keun HC. 2014. Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS. J Proteome Res. 13:883–9. doi:10.1021/pr400924k.
Garcia FAR, Cornelison T, Nuño T, Greenspan DL, Byron JW, Hsu C-H, Alberts DS, Chow H-HS. 2014. Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia. Gynecol Oncol. 132:377–82. doi:10.1016/j.ygyno.2013.12.034.
Zhao F, Malm SW, Hinchman AN, Li H, Beeks CG, Klimecki WT. 2014. Arsenite-induced pseudo-hypoxia results in loss of anchorage-dependent growth in BEAS-2B pulmonary epithelial cells. PLoS One. 9:e114549. doi:10.1371/journal.pone.0114549.
Dagher J, Reese T, Bilgin A. 2014. High-resolution, large dynamic range field map estimation. Magn Reson Med. 71:105–17. doi:10.1002/mrm.24636.
Watson JM, Marion SL, Rice PF, Bentley DL, Besselsen DG, Utzinger U, Hoyer PB, Barton JK. 2014. In vivo time-serial multi-modality optical imaging in a mouse model of ovarian tumorigenesis. Cancer Biol Ther. 15:42–60. doi:10.4161/cbt.26605.
Buchan JR. 2014. mRNP granules. Assembly, function, and connections with disease. RNA Biol. 11:1019–30. doi:10.4161/15476286.2014.972208.
Rogowitz E, Babiker HM, Kanaan M, Millius RA, Ringenberg QS, Bishop M. 2014. Neuroblastoma of the elderly, an oncologist’s nightmare: case presentation, literature review and SEER database analysis. Exp Hematol Oncol. 3:20. doi:10.1186/2162-3619-3-20.
Segrin C, Badger TA. 2014. Psychological and physical distress are interdependent in breast cancer survivors and their partners. Psychol Health Med. 19:716–23. doi:10.1080/13548506.2013.871304.
Mondal SB, Gao S, Zhu N, Liang R, Gruev V, Achilefu S. 2014. Real-time fluorescence image-guided oncologic surgery. Adv Cancer Res. 124:171–211. doi:10.1016/B978-0-12-411638-2.00005-7.
Taverna JA, Babiker HM, Yun S, Bishop MC, Lau-Braunhut S, Meyer PN, Enzler T. 2014. The great masquerader of malignancy: chronic intestinal pseudo-obstruction. Biomark Res. 2:23. doi:10.1186/s40364-014-0023-y.
2013
Larsen BT, Bishop MC, Hunter GC, Renner SW. 2013. Low-grade, metastasizing splenic littoral cell angiosarcoma presenting with hepatic cirrhosis and splenic artery aneurysm. Int J Surg Pathol. 21:618–26. doi:10.1177/1066896913476737.
Loescher LJ, Hansen C, Hepworth JT, Quale L, Sligh J. 2013. A preliminary study of a video intervention to inform solid organ transplant recipients about skin cancer. Transplant Proc. 45:3187–9. doi:10.1016/j.transproceed.2012.09.118.
Heinz S, Romanoski CE, Benner C, Allison KA, Kaikkonen MU, Orozco LD, Glass CK. 2013. Effect of natural genetic variation on enhancer selection and function. Nature. 503:487–92. doi:10.1038/nature12615.
Hart MR, Su H-Y, Broka D, Goverdhan A, Schroeder JA. 2013. Inactive ERBB Receptors Cooperate With Reactive Oxygen Species To Suppress Cancer Progression. Molecular Therapy. 21(11):1996–2007. doi:10.1038/mt.2013.196.
Klebba JE, Buster DW, Nguyen AL, Swatkoski S, Gucek M, Rusan NM, Rogers GC. 2013. Polo-like kinase 4 autodestructs by generating its Slimb-binding phosphodegron. Curr Biol. 23:2255–2261. doi:10.1016/j.cub.2013.09.019.
Tula-Sanchez AA, Havas AP, Alonge PJ, Klein ME, Doctor SR, Pinkston W, Glinsmann-Gibson BJ, Rimsza LM, Smith CL. 2013. A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitors. Cancer Biol Ther. 14:949–61. doi:10.4161/cbt.25941.
Kadiyala V, Patrick NM, Mathieu W, Jaime-Frias R, Pookhao N, An L, Smith CL. 2013. Class I lysine deacetylases facilitate glucocorticoid-induced transcription. J Biol Chem. 288:28900–12. doi:10.1074/jbc.M113.505115.
Sugeng AJ, Beamer PI, Lutz EA, Rosales CB. 2013. Hazard-ranking of agricultural pesticides for chronic health effects in Yuma County, Arizona. Sci Total Environ. 463-464:35–41. doi:10.1016/j.scitotenv.2013.05.051.